Publication of Admission Particulars

By

Regulatory News | 14 Nov, 2024

Updated : 07:02

RNS Number : 1692M
Bunzl PLC
14 November 2024
 

Bunzl Finance Plc - LEI: 549300G276IH2GSE0E88
Bunzl plc - LEI: 213800Q1Q9DV4L78UM09

 

THIS ANNOUNCEMENT IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

 

 

14 November 2024

 

BUNZL FINANCE PLC

 

ANNUAL UPDATE OF EURO MEDIUM TERM NOTE PROGRAMME AND PUBLICATION OF ADMISSION PARTICULARS

 

 

Bunzl Finance plc, a wholly-owned finance subsidiary of Bunzl plc, today announces the annual renewal of its Euro Medium Term Note Programme (the "Programme") and the increase in the maximum aggregate nominal amount of the Programme from £1,500,000,000 to £2,000,000,000.

 

As part of the annual renewal of the Programme, the following admission particulars (the "Admission Particulars") have been submitted to and approved by the International Securities Market of the London Stock Exchange:

 

Admission Particulars dated 13 November 2024 relating to the £2,000,000,000 Euro Medium Term Note Programme of Bunzl Finance plc, as Issuer, which is unconditionally and irrevocably guaranteed by Bunzl plc, as Guarantor.

 

A copy of the Admission Particulars can be viewed on Bunzl plc's website at https://www.bunzl.com/investors/shareholder-information/debt-information/

 

This website is not provided for, or directed at, U.S. persons or persons in the United States. If you are a U.S. person or are viewing this page from the United States, you should exit this section of the website.

 

For further information, please contact:

 

Bunzl Finance plc

York House,

45 Seymour Street

London

W1H 7JT

United Kingdom

 

Email: Suzanne.Jefferies@Bunzl.com

Attention: Suzanne Jefferies

 

DISCLAIMER - INTENDED ADDRESSES

Please note that the information contained in the Admission Particulars may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Admission Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Admission Particulars is not addressed. Prior to relying on the information contained in the Admission Particulars you must ascertain from the Admission Particulars whether or not you are part of the intended addressees of the information contained therein.

The Admission Particulars do not constitute an offer of securities for sale in the United States. The notes described herein and in the Admission Particulars have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) , except pursuant to an exemption from the Securities Act. For a further description of certain restrictions on offers and sales of the notes and on distribution of the Admission Particulars, see the "Subscription and Sale" section in the Admission Particulars.

Your right to access this service is conditional upon complying with the above requirement.

No offer or invitation to acquire any securities is being made pursuant to this announcement.

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCFXLLFZFLLFBX

Last news